Big win for the life sciences: Northwestern to co-lead new Chan Zuckerberg Biohub Chicago
The Chan Zuckerberg Initiative (CZI) has selected Northwestern University to co-lead its new biomedical research hub in Chicago, which will develop new technologies for studying human tissues with unprecedented resolution. The hub’s ultimate goal is to unite the region’s best researchers to improve understanding of inflammation, potentially leading to new treatments for the inflammatory conditions that underlie disease.
Northwestern will co-lead the Chan Zuckerberg Biohub Chicago (CZ Biohub Chicago) with the University of Chicago and the University of Illinois, Urbana-Champaign. Shana O. Kelley, the Neena Schwartz Professor of Chemistry and Biomedical Engineering at Northwestern, will serve as the hub’s president.
CZI selected the Chicago team from a pool of 58 teams after a yearlong, highly competitive application process for a research initiative explicitly focused on measuring human biology.